Search results
Results from the WOW.Com Content Network
Known as "the godfather of cannabis research", Mechoulam is best known for his work (together with Y. Gaoni) in the isolation of tetrahydrocannabinol, or THC, the main active principle of cannabis. [ 1 ] [ 6 ] [ 7 ] He was also successful in the isolation and identification of the endogenous cannabinoids anandamide from the brain and 2 ...
Legal cannabis (marijuana) product. Overconsumption and reliance could lead to cannabis-induced amotivational syndrome. The term amotivational syndrome was first devised to understand and explain the diminished drive and desire to work or compete among the population of youth who are frequent consumers of cannabis and has since been researched through various methodological studies with this ...
A dried cannabis flower. The short-term effects of cannabis are caused by many chemical compounds in the cannabis plant, including 113 [clarification needed] different cannabinoids, such as tetrahydrocannabinol, and 120 terpenes, [1] which allow its drug to have various psychological and physiological effects on the human body.
Nabilone can increase – rather than decrease – postoperative pain. [citation needed] In the treatment of fibromyalgia, adverse effects limit the useful dose. [4]Adverse effects of nabilone include, but are not limited to: dizziness/vertigo, euphoria, drowsiness, dry mouth, ataxia, sleep disturbance, headache, nausea, disorientation, depersonalization, hallucinations, and asthenia.
CBN was the first cannabinoid to be isolated from cannabis extract in the late 1800s. Specifically, it was discovered by Barlow Wood, Newton Spivey, and Easterfield in 1896. [ 21 ] In the early 1930s, CBN's structure was identified by Cahn , [ 22 ] [ 23 ] marking the first development of a cannabis extract .
A cannabis plant includes more than 400 different chemicals, of which about 70 are cannabinoids. [15] In comparison, typical government-approved medications contain only one or two chemicals. [15] The number of active chemicals in cannabis is one reason why treatment with cannabis is difficult to classify and study. [15]
Researchers found that 63% of lifetime heavy cannabis-using participants and 68% of recent cannabis users showed reduced brain activity during their working memory task.
South Korea's National Forensic Service reported that 90% of all seized synthetic cannabinoids in 2013 were fluorinated, compared to no fluorinated synthetic cannabinoids reported in 2010. 5F-derivations (terminal fluorination) of the synthetic cannabinoids have been found to be about 2–5 times more potent at CB 1 receptors than their un ...